FCN · XBRL financial data
Fti Consulting financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (FCN's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | year only | — | — | — | year only | — | — | — | year only | — | — | — |
| Revenue from contracts with customers | 925* | 929 | 949 | 926 | 895* | 898 | 944 | 956 | 991* | 983 | 993 | 1,013 |
| Cost of revenue | 614* | 626 | 638 | 628 | 625* | 609 | 641 | 638 | 683* | 677 | 677 | 662 |
| Gross profit | 311* | 303 | 311 | 298 | 270* | 289 | 303 | 318 | 308* | 307 | 316 | 351 |
| Selling, general and administrative | 195* | 202 | 206 | 206 | 208* | 184 | 202 | 199 | 214* | 222 | 231 | 214 |
| Operating income (loss) | 115* | 100 | 104 | 91 | 53* | 79 | 99 | 118 | 93* | 84 | 85 | 90 |
| Interest expense | 4* | 2 | 3 | 1 | 1* | 1 | 5 | 8 | 8* | 6 | 12 | 13 |
| Other income (expense) | year only | — | — | — | year only | — | — | — | year only | — | — | — |
| Income tax expense (benefit) | 21* | 20 | 19 | 22 | 10* | 19 | 20 | 29 | 32* | 21 | 15 | 14 |
| Net income (loss) | 82* | 80 | 84 | 66 | 50* | 62 | 72 | 83 | 55* | 58 | 58 | 63 |
| Earnings per share, basic USD per share | 2.34* | 2.29 | 2.38 | 1.88 | 1.41* | 1.76 | 2.16 | 2.63 | 1.80* | 1.92 | 2.01 | 2.37 |
| Earnings per share, diluted USD per share | 2.28* | 2.23 | 2.34 | 1.85 | 1.39* | 1.74 | 2.13 | 2.60 | 1.78* | 1.90 | 1.99 | 2.35 |
| Weighted average shares, basic millions of shares | 35* | 35 | 35 | 35 | 35* | 35 | 33 | 32 | 30* | 30 | 29 | 27 |
| Weighted average shares, diluted millions of shares | 36* | 36 | 36 | 36 | 36* | 36 | 34 | 32 | 31* | 30 | 29 | 27 |
Balance sheet
CSVFiscal quarters (FCN's year ends in late December)
Cash flows
CSVFiscal quarters (FCN's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 82* | 80 | 84 | 66 | 50* | 62 | 72 | 83 | 55* | 58 | 58 | 63 |
| Stock-based compensation | 8* | 9 | 9* | 10* | 10* | 10 | 10* | 9* | 11* | 11 | 11* | 10* |
| Net cash from operating activities | 383* | (275) | 135* | 219* | 315* | (465) | 56* | 202* | 360* | (310) | 152* | 190* |
| Purchases of property and equipment | 6* | 5 | 10* | 7* | 14* | 18 | 17* | 15* | 8* | 11 | 11* | 8* |
| Net cash from investing activities | (6)* | 21 | (10)* | (7)* | (14)* | (18) | (17)* | (15)* | (8)* | (11) | (53)* | (8)* |
| Share repurchases | 0* | 0 | 0* | 0* | 10* | 183 | 354* | 234* | 88* | 127 | 393* | 85* |
| Proceeds from long-term debt | — | — | — | — | — | 0 | 0* | 0* | — | 300 | 0* | 0* |
| Net cash from financing activities | (288)* | 199 | (140)* | (63)* | (11)* | (32) | (52)* | (193)* | (233)* | 258 | (134)* | (257)* |
| Net change in cash | 102* | (59) | (18)* | 160* | 274* | (509) | 2* | (7)* | 119* | (67) | (35)* | (76)* |
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Fti Consulting | 88 | 1,013 | 190* | 27.3M | — | 10-QSep 30, 2026 |
| Exponent | 67 | 172 | 31* | 47.5M | — | 10-QJul 3, 2026 |
| Genpact | 517 | 1,343 | 72* | 168.0M | — | 10-QJun 30, 2026 |
| Huron Consulting Group | 26 | 491 | 57* | 15.8M | — | 10-QSep 30, 2026 |
| Premier | 43 | 240 | 16 | 82.7M | — | 10-QSep 30, 2025 |
| Booz Allen Hamilton Holding | 334 | 2,778 | 294* | 118.6M | — | 10-QSep 30, 2026 |
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.